GRAPHICAL USER INTERFACES FOR DETERMINING PERSONALIZED ENDOCANNABINOID GENOTYPES AND ASSOCIATED RECOMMENDATIONS

Patent №

US 11,612,582

Granted

2023-03-28

Filed 2020

Owner

ENDOCANNA HEALTH, INC.

Lab

AI components

1

kr

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

16760155

An example embodiment may involve (i) receiving, by a server device, deoxyribonucleic acid (DNA) information associated with a user; (ii) parsing, by the server device, the DNA information to identify one or more single nucleotide polymorphisms (SNPs)—(iii) determining, by the server device and based, on the identified SNPs, an endocannabinoid genotype of the user; (iv) determining, based on the endocannabinoid genotype of the user, a recommendation of one or more cannabinoid formulations; (v) transmitting, to a client device associated with the user, a web-based representation of a first graphical user interface; and (vi) receiving, from the client device, an indication to display a detailed representation of a particular cannabinoid formulation of the one or more cannabinoid formulations.

Knowledge representationA61K 31/05A61K 31/658A61K 31/015A61K 31/035A61K 31/045A61K 31/352A61P 25/00A61P 25/22+14 more

AI classification

Knowledge representation0.64
Machine learning0.18
Planning0.01
Evolutionary computation0.00
AI hardware0.00
Vision0.00
Natural language0.00
Speech0.00

Ownership

ENDOCANNA HEALTH, INC.

assignment · 545510810

Assignors

MAY, LEN, KAUFMAN, ERIC

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC